T. Rowe Price Associates
SHC icon

T. Rowe Price Associates’s Sotera Health SHC Stock Holding History

T. Rowe Price Associates’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64M Buy
261,396
+48,644
+23% +$767K ﹤0.01% 1605
2026
Q1 		$3.05M Buy
212,752
+53,314
+33% +$885K ﹤0.01% 1639
2025
Q4 		$2.81M Buy
159,438
+42,176
+36% +$698K ﹤0.01% 1608
2025
Q3 		$1.84M Buy
117,262
+16,736
+17% +$235K ﹤0.01% 1766
2025
Q2 		$1.12M Buy
100,526
+2,948
+3% +$34.5K ﹤0.01% 1941
2025
Q1 		$1.14M Buy
97,578
+7,910
+9% +$102K ﹤0.01% 1889
2024
Q4 		$1.23M Buy
89,668
+15,156
+20% +$220K ﹤0.01% 1882
2024
Q3 		$1.25M Buy
74,512
+12,458
+20% +$182K ﹤0.01% 1879
2024
Q2 		$737K Buy
62,054
+2,574
+4% +$29.4K ﹤0.01% 2024
2024
Q1 		$715K Buy
59,480
+12,195
+26% +$181K ﹤0.01% 2058
2023
Q4 		$797K Buy
47,285
+2,522
+6% +$35.7K ﹤0.01% 1973
2023
Q3 		$671K Buy
44,763
+1,354
+3% +$22.8K ﹤0.01% 1974
2023
Q2 		$818K Sell
43,409
-231
-0.5% -$3.67K ﹤0.01% 1900
2023
Q1 		$782K Buy
43,640
+18,042
+70% +$301K ﹤0.01% 1904
2022
Q4 		$213K Buy
25,598
+4,614
+22% +$34.4K ﹤0.01% 2505
2022
Q3 		$144K Buy
20,984
+8,028
+62% +$133K ﹤0.01% 2636
2022
Q2 		$254K Buy
+12,956
New +$271K ﹤0.01% 2513

Other funds holding SHC

SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
DCP
Darsana Capital Partners New York $22.3B AUM 42.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM

T. Rowe Price Associates's SHC Position: Q2 2026 in Review

T. Rowe Price Associates increased its Sotera Health (SHC) stake by 23% in Q2 2026, buying an estimated $767K and bringing the position to 261,396 shares worth $4.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1605.

T. Rowe Price Associates first reported a position in SHC in Q2 2022 and has held it in 17 quarters since. 320 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • T. Rowe Price Associates held 261,396 shares of Sotera Health worth $4.64M as of Q2 2026.
  • T. Rowe Price Associates bought 48,644 Sotera Health shares in Q2 2026, an estimated $767K.
  • Sotera Health made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #1605 holding.
  • T. Rowe Price Associates first reported a position in Sotera Health in Q2 2022 and has held it in 17 quarters since.
  • 320 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.